Blend + GHK-Cu Set
BPC-157 + TB-500 Blend 20mg + GHK-Cu 50mg. A combined repair and dermal-matrix research set.
$156.00$183.00Notify me
CJC-1295 + Ipamorelin Set
CJC-1295 + Ipamorelin Blend 10mg + Ipamorelin 10mg. GHRH analog and ghrelin-receptor agonist research set.
- Test methods
- HPLC-UV + LC-MS
- Purity target
- 99%+ verified
- Sizes available
- 1
- Availability
- Backordered
Select size
Quantity
1
Total
$111.00
That's the price. No inflated list, no permanent “discount” code to make it look cheaper than it is.
Certificate for this lot is pending. Every batch we ship is published at /coa before it goes out.
For Research Use Only. Not for Human Consumption.
Products supplied by Synthrex Biotech LLC are intended strictly for in-vitro laboratory research and development by qualified professionals. They are not drugs, foods, cosmetics, or dietary supplements, and are not approved by the FDA for human or veterinary use. They are not sold for, and must not be used for, human or animal consumption or administration of any kind. Synthrex Biotech LLC is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, and is not an outsourcing facility as defined under section 503B of that Act. By purchasing, you affirm that you are a qualified researcher acquiring these materials for lawful research purposes only. A Safety Data Sheet (SDS/MSDS) is available on request for every compound.
Sold by Synthrex Biotech LLC. A Safety Data Sheet (SDS) is available on request at support@synthrexbiotech.com.
✦ Contents
What is in this set
Every vial carries its own batch number and its own published certificate, exactly as it would if bought separately. No published literature characterises this combination as a single entity.
CJC-1295 + Ipamorelin Blend 10mg
A combined GHRH analog and ghrelin-receptor agonist preparation used in secretagogue research.
A co-formulation of two compounds that act on different receptors: CJC-1295, a GHRH-receptor analog developed by ConjuChem, and ipamorelin, a selective growth-hormone secretagogue described by Novo Nordisk researchers in 1998. The pairing is a supplier formulation; the combination itself has no independent discovery history or characterisation.
Full research notes and sources for CJC-1295 + Ipamorelin Blend →Ipamorelin 10mg
A selective ghrelin-receptor agonist studied in growth-hormone release research.
Ipamorelin was described in 1998 by a group at Novo Nordisk and introduced in the literature as “the first selective growth hormone secretagogue.” The selectivity claim is the historically interesting part: earlier secretagogues in this class also produced measurable effects on other pituitary hormones, and ipamorelin was characterised as acting on growth-hormone release without that broader profile in the models tested. It is a synthetic pentapeptide.
Full research notes and sources for Ipamorelin →Batch releases & restocks
Know when the next batch is tested
We publish an independent certificate for every lot before it ships. Join the Lab List and we'll tell you when a new one lands and when a sold-out compound is back — plus 15% off your first order, shown on screen the second you join.
Batch and restock notices from Synthrex Biotech LLC. No dosing advice, ever. One-click unsubscribe on every email.
Related Compounds
GLOW + GHK-Cu Set
GLOW Blend 70mg + GHK-Cu 50mg. Copper-peptide focused preparation set for dermal research models.
$108.00$127.00View
KLOW + KPV Set
KLOW Blend 80mg + KPV 10mg. A four-compound blend paired with an alpha-MSH fragment for multi-pathway research.
$120.00$141.00View
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.